World of DTC Marketing

AUGUST 12, 2022

In the past 12 months, PhRMA and closely allied groups spent at least $57 million — $19 million of it since July — on TV , cable , radio , and social media ads opposing price negotiations, according to monitoring by the advocacy group Patients for Affordable Drugs. First, let’s clarify how the bill saves taxpayers billions.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

Healthcare Success

JANUARY 25, 2023

However, these numbers escalated in 2020, along with the COVID-19 pandemic. Negative or angry emotions According to her survey of 70,000 “The Mighty” readers and community members, the number of people choosing anger as their top emotion more than doubled from March to September 2020— rising from 20% to 45%. How did we get here?

Patients 105

Patients Healthcare Healthcare Management 105

European Pharmaceutical Review

AUGUST 10, 2022

A study published in Nature Medicine demonstrates that active brain metastases in breast cancer patients are partially or even completely regressed by an antibody-drug conjugate (ADC), trastzumab deruxtecan (T-Dxd). T-Dxd was found to have a high intracranial response rate in patients with active brain metastases. percent of patients.

Patients 98

Patients Medicine Prospecting Safety 98

Pharma Marketing Network

NOVEMBER 11, 2020

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact .

Marketing 52

Marketing Pharma Competition Doctors 52

Pharma Marketing Network

MAY 3, 2023

However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

Pharmaceutical Technology

FEBRUARY 2, 2023

It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD. We are proud to have developed Jesduvroq as a new oral treatment where there is a patient desire for more options.” dL) for the patients.

Food and Drug Administration 105

Food and Drug Administration FDA Safety Food 105

Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.

Marketing 59

Marketing Side effects Sales Safety 59

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 96

Patients Pharma Consulting Transportation 96

Pharma Marketing Network

APRIL 27, 2021

HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. Head of the Discovery Technology Center in Cambridge, Massachusetts, Head of Discovery Research in Ann Arbor, Michigan, and Head of Drug Safety R&D. The post Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor appeared first on Pharma Marketing Network.

Medicine 52

Medicine Networking Safety Marketing 52

European Pharmaceutical Review

JULY 14, 2022

Pfizer’s Hospira is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100ml Single Patient Use Glass Fliptop Vial; lot DX9067, to the user level due to a visible particulate observed in a single vial during annual examination of retain samples. 1 g/100 mL, Single Patient Use Glass Fliptop Vial.

Distribution 105

Distribution Patients Safety Manufacturing 105

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Pharmaceutical Technology

APRIL 3, 2023

Eisai and the National Cancer Center have signed an agreement to partner on investigator-initiated clinical research for the anti-cancer agent, tazemetostat (Tazverik Tablets 200 mg), based on the Patient-Proposed Healthcare Services system.

Insurance 98

Insurance Government Safety Patients 98

pharmaphorum

AUGUST 24, 2022

The biotech has confirmed it will not launch the biosimilar until March 2025 however, honouring the terms of its 2020 agreement with Alexion that resolved litigation over the validity of patents covering Soliris (eculizumab) in the US.

Safety 98

Safety Sales Patients FDA 98

Infuse Medical

JULY 4, 2024

A 2020 study from Stanford University showed that VR training reduced maintenance errors by 35%. Brief Overview of the Importance of Medical Device Maintenance Medical device maintenance ensures patient safety, operational efficiency, and regulatory compliance in healthcare settings. What is VR Training?

Training 130

Training Medical Healthcare Healthcare 130

pharmaphorum

SEPTEMBER 27, 2022

It comes after Johnson & Johnson’s Janssen Biotech division signed up to access the bispecific antibody technology in 2020, without revealing any financial details. 2 T cells, which have potent tumour-killing activity. Image by WikiImages from Pixabay.

Safety 111

Safety FDA Sales Leads 111

pharmaphorum

AUGUST 23, 2022

France’s BrainVectis, a subsidiary of Bayer’s Asklepios BioPharma (AskBio) unit, has been given the green light by regulators in France to start dosing patients with its gene therapy candidate for devastating neurodegenerative disorder Huntington’s disease.

Safety 105

Safety Biopharma Patients 105

pharmaphorum

NOVEMBER 2, 2022

With the merger now completed, Norstella becomes a $5 billion group with 1,500 employees across the five business brands with the overarching objective of guiding life sciences companies through the drug development process so patients can get access to therapies more quickly. Photo by Edge2Edge Media on Unsplash.

Pharma 101

Pharma Marketing Patients Consulting 101

Pharmaceutical Technology

NOVEMBER 9, 2022

Despite their potential multi-million-dollar sticker price, if haemophilia treatments by BioMarin and CSL Behring prove durable, they could help patients save money compared to current treatments, experts note. A previous October 2020 report concluded that longer-term safety and efficacy were needed to update health-benefit price benchmarks.

Safety 111

Safety Pharmaceutical Patients Medicine 111

European Pharmaceutical Review

SEPTEMBER 20, 2023

The growing presence of these unintended amino acid sequences in recombinant proteins is a top concern for regulators and drug manufacturers due to the ability of these mutations to cause higher order structural problems, potentially affecting efficacy and safety. 2020; 38, 540-545. 2020; 12(1): 1791399. Nat Biotechnol.

Patients 98

Patients Manufacturing Leads Safety 98

Pharmaceutical Technology

JULY 4, 2022

In June 2020, Brii Bio exercised its option and acquired the exclusive rights for the further development and marketing of BRII-835 (VIR-2218) in Greater China. We are confident that this new asset further strengthens our HBV pipeline by providing more potent and assured reduction of HBsAg in all patients.

Medical 111

Medical Safety Marketing Sales 111

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. 3 Moreover, digital platforms can be tailored to the needs of patients and healthcare professionals, offering accessible, trustworthy and up-to-date information on medicines precisely when required.

Healthcare 98

Healthcare Healthcare Safety Medicine 98

Pharmaceutical Technology

JANUARY 23, 2023

The term LN refers to a major predictor of poor prognosis in SLE patients, with inflammation of the kidney that encompasses diverse patterns of renal disease, including glomerular and vascular pathology. In previous years, Benlysta has managed to grow the lupus market in terms of value, having generated approximately $492.9m

Marketing 111

Marketing Safety Patients Pharmaceutical 111

pharmaphorum

NOVEMBER 22, 2022

Some patients will be able to continue to receive the drug via a compassionate use programme. GSK had great expectations for Blenrep, which was approved in 2020 for multiple myeloma patients who have received at least four prior therapies – including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.

Marketing 105

Marketing FDA Patients Sales 105

pharmaphorum

DECEMBER 14, 2022

When patients experience intense emotion, either positive or negative, they are rendered unconscious. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process.

Competition 116

Competition FDA Pharmaceutical Marketing 116

European Pharmaceutical Review

JANUARY 29, 2024

Overall, the authors summarised that the enhanced sensitivity improves safety assessments for volatiles in medical devices. The paper discussed the detection of volatile extractables released during the clinical use of medical devices.

Food and Drug Administration 98

Food and Drug Administration Medical Safety Food 98

pharmaphorum

JANUARY 4, 2023

More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic syndromes (MDS). “True innovation is a lot harder than it sounds,” he said. “And this isn’t the ultimate victory lap today.

Safety 98

Safety Marketing Patients Pharma 98

European Pharmaceutical Review

AUGUST 11, 2023

Crizanlizumab is a once-a-month, humanised monoclonal antibody infusion, indicated for the prevention of recurrent vaso‑occlusive crises (pain crises) in sickle cell disease patients aged 16 years and above. Adakveo (crizanlizumab) received conditional authorisation by the EC in October 2020.

Marketing 98

Marketing Food and Drug Administration Medicine FDA 98

European Pharmaceutical Review

DECEMBER 6, 2022

In July 2021, the French temporary authorisation for use (Autorisation Temporaire d’Utilisation, ATU) programme was the subject of a major reform, initially published within the 2021 healthcare plan on the 14th December 2020 (Article 78 – La Loi de financement de la sécurité sociale , FSSL).

Patients 98

Patients Manufacturing Safety Healthcare 98

European Pharmaceutical Review

MAY 2, 2023

Ultimately, the regulatory body hopes the approach will result in more treatment options and improved patient outcomes. This draft guidance builds on recommendations published by the agency in 2020. The FDA’s regulatory requirements for investigations of medical products are the same for DCTs and traditional site-based clinical trials.

FDA 98

FDA Food and Drug Administration Medical Food 98

European Pharmaceutical Review

SEPTEMBER 2, 2022

To ensure the safety of medicines post-regulatory approval, a risk management plan (RMP) is established. However, the importance of rigorous documentation of the sampling strategy has also been underlined in recent guidelines related to another research field, patient preference studies. What are risk minimisation methods?

Food and Drug Administration 96

Food and Drug Administration Medicine Safety Food 96

European Pharmaceutical Review

MAY 4, 2023

Data announced at the European Lung Cancer Congress (ELCC) earlier this month revealed the long-term efficacy and safety of RYBREVANT ® (amivantamab) in patients with post-platinum EGFR Ex20ins-mutated advanced non-small cell lung cancer (NSCLC). 4 Amivantamab targets the extracellular portion of the EGFR and MET receptors.

Food and Drug Administration 98

Food and Drug Administration Safety Patients Medicine 98

pharmaphorum

DECEMBER 5, 2022

The French biotech says VLA1553 met its objective in the phase 3 study, with 99% of patients exhibiting an antibody response against the virus 12 months after receiving a single dose of the shot, with no evidence of a tailing off in levels in the last six months. It will continue for up to five years.

Safety 98

Safety Marketing Patients FDA 98

European Pharmaceutical Review

NOVEMBER 20, 2023

“This state-of-the-art parenteral site with the latest technology will enable us to continue to deliver medicines with safety first and quality always around the world,” stated Edgardo Hernandez, Executive Vice President and President of Eli Lilly’s manufacturing operations.

Manufacturing 98

Manufacturing Medicine Biopharma Engineering 98

European Pharmaceutical Review

APRIL 12, 2023

The platform is “designed to cross the blood-brain barrier (BBB) and safely increase exposure of the therapeutic antibody in the brain and potentially lead to improved efficacy and/or safety,” stated Joseph Lewcock, PhD, Chief Scientific Officer of Denali. Denali will receive a one-time option exercise payment.

Transportation 102

Transportation Engineering Safety Sales 102

European Pharmaceutical Review

MAY 8, 2024

Based on the growing evidence of positive outcomes seen with full ecosystem products, mbiomics has developed a proprietary techbio platform that aims to combine the disease-modifying potential of large consortia with the safety and scalable manufacturability of GMP-manufactured non-engineered microbial strains isolated from healthy individuals.

Manufacturing 98

Manufacturing Safety FDA Patients 98

Pharma Marketing Network

JULY 19, 2023

This could include sponsoring research into new drugs and treatments, providing educational resources about health conditions, or supporting patient care programs. This could help to improve the lives of patients and make a real difference in the world. This could help to ensure that everyone has access to the care they need.

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98

pharmaphorum

JANUARY 27, 2023

It failed a futility test in a pivotal trial and was also placed under a partial clinical hold by the FDA in 2020 while a safety signal was investigated. Palovarotene was acquired by Ipsen as part of its $1 billion upfront acquisition of Clementia Pharma in 2019, but almost immediately ran into trouble.

FDA 98

FDA Marketing Medicine Prospecting 98